1. Preclinical Research: Initial studies in the lab and in animal models to evaluate the efficacy and safety of the nanomaterial. 2. Regulatory Approval: Submitting data to regulatory bodies such as the FDA or EMA for approval to proceed with human clinical trials. 3. Clinical Trials: Conducting phased human trials to assess safety, dosage, efficacy, and side effects. 4. Manufacturing and Scaling Up: Developing scalable and reproducible manufacturing processes. 5. Market Authorization: Gaining final approval from regulatory agencies to market the product. 6. Post-Market Surveillance: Ongoing monitoring for long-term effects and real-world efficacy.
